Cargando…

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection

BACKGROUND: Monitoring the adaptive immune responses during the natural course of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection provides useful information for the development of vaccination strategies against this virus and its emerging variants. We thus profiled the serum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sherina, Natalia, Piralla, Antonio, Du, Likun, Wan, Hui, Kumagai-Braesch, Makiko, Andréll, Juni, Braesch-Andersen, Sten, Cassaniti, Irene, Percivalle, Elena, Sarasini, Antonella, Bergami, Federica, Di Martino, Raffaella, Colaneri, Marta, Vecchia, Marco, Sambo, Margherita, Zuccaro, Valentina, Bruno, Raffaele, Sachs, Michele, Oggionni, Tiberio, Meloni, Federica, Abolhassani, Hassan, Bertoglio, Federico, Schubert, Maren, Byrne-Steele, Miranda, Han, Jian, Hust, Michael, Xue, Yintong, Hammarström, Lennart, Baldanti, Fausto, Marcotte, Harold, Pan-Hammarström, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Inc. 2021
Materias:	Clinical and Translational Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874960/ https://www.ncbi.nlm.nih.gov/pubmed/33589885 http://dx.doi.org/10.1016/j.medj.2021.02.001

Ejemplares similares

Immunity to SARS-CoV-2 up to 15 months after infection
por: Marcotte, Harold, et al.
Publicado: (2022)

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
por: Zuo, Fanglei, et al.
Publicado: (2022)

Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
por: Zuo, Fanglei, et al.
Publicado: (2023)

SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay
por: Cassaniti, Irene, et al.
Publicado: (2021)

Antibody therapy for COVID-19
por: Hammarström, Lennart, et al.
Publicado: (2021)

Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients—a perspective
por: Hammarström, Lennart, et al.
Publicado: (2020)

Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study
por: Cassaniti, Irene, et al.
Publicado: (2022)

SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults
por: Björkander, Sophia, et al.
Publicado: (2022)

Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit
por: Colaneri, M., et al.
Publicado: (2020)

Authors’ response: COVID-19: how accurate are seroprevalence studies?
por: Cassaniti, Irene, et al.
Publicado: (2020)

Impact of Viral Decontamination Method on Cytokine Profile of COVID-19 Patients
por: Magrì, Davide, et al.
Publicado: (2021)

Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital
por: Sammartino, Josè Camilla, et al.
Publicado: (2022)

Design, structure and plasma binding of ancestral β-CoV scaffold antigens
por: Hueting, David, et al.
Publicado: (2023)

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
por: Schubert, Maren, et al.
Publicado: (2022)

SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers
por: Rovida, Francesca, et al.
Publicado: (2021)

ApoD Mediates Binding of HDL to LDL and to Growing T24 Carcinoma
por: Braesch-Andersen, Sten, et al.
Publicado: (2014)

Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers
por: Bergami, Federica, et al.
Publicado: (2022)

Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant
por: Cassaniti, Irene, et al.
Publicado: (2021)

ApoE Production in Human Monocytes and Its Regulation by Inflammatory Cytokines
por: Braesch-Andersen, Sten, et al.
Publicado: (2013)

Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients
por: Baldanti, Fausto, et al.
Publicado: (2011)

Molecular Epidemiology of Rhinovirus/Enterovirus and Their Role on Cause Severe and Prolonged Infection in Hospitalized Patients
por: Giardina, Federica A. M., et al.
Publicado: (2022)

Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients
por: Gerna, Giuseppe, et al.
Publicado: (2007)

SARS-CoV-2 positivity in rectal swabs: implication for possible transmission
por: Novazzi, Federica, et al.
Publicado: (2020)

Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy
por: Colaneri, M., et al.
Publicado: (2020)

West Nile or Usutu Virus? A Three-Year Follow-Up of Humoral and Cellular Response in a Group of Asymptomatic Blood Donors
por: Percivalle, Elena, et al.
Publicado: (2020)

Interactive Visual Intervention Planning: Interactive Visualization for Intervention Planning in Particle Accelerator Environments with Ionizing Radiation
por: Fabry, Thomas, et al.
Publicado: (2013)

Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment
por: Lasagna, A., et al.
Publicado: (2022)

Zika Virus Infection in Pregnancy: Advanced Diagnostic Approaches in Dengue-Naive and Dengue-Experienced Pregnant Women and Possible Implication for Cross-Reactivity and Cross-Protection
por: Zavattoni, Maurizio, et al.
Publicado: (2019)

Thirteen Years of Phleboviruses Circulation in Lombardy, a Northern Italy Region
por: Percivalle, Elena, et al.
Publicado: (2021)

Real-life lack of evidence of viable SARS-CoV-2 transmission via inanimate surfaces: The SURFACE study
por: Sammartino, José Camilla, et al.
Publicado: (2023)

SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders
por: Benazzo, Marco, et al.
Publicado: (2020)

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
por: Marcotte, Harold, et al.
Publicado: (2022)

Hallmarks of Cancers: Primary Antibody Deficiency Versus Other Inborn Errors of Immunity
por: Abolhassani, Hassan, et al.
Publicado: (2021)

SARS-CoV-2 infection in patients with inborn errors of immunity due to DNA repair defects: DNA repair deficiency and COVID19
por: Wang, Yating, et al.
Publicado: (2022)

T-lymphocyte subsets in lung transplant recipients: association between nadir CD4 T-cell count and viral infections after transplantation
por: Calarota, Sandra A., et al.
Publicado: (2015)

Developing an interactive intervention planner: a systems engineering perspective
por: Fabry, Thomas, et al.
Publicado: (2013)

Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients
por: Cassaniti, Irene, et al.
Publicado: (2022)

Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy
por: Colaneri, Marta, et al.
Publicado: (2022)

Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study
por: Lasagna, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sun8df7affgdrafe08it5ebc39